Otsuka Pharma (Japanese) just bid CAD$80m (Aussie $90m) for Mindset Pharma to acquire their pre-clinical pipeline of psychedelic assets. Otsuka has a US$20 billion market cap and paid cash for this acquisition, which is the equivalent of IXHL’s entire EV.
Otsuka is a company to watch IMO, they are getting innovative and aggressive in the neurology space.
Start reading between the lines, form an opinion on value and watch what happens when this company hits the NASDAQ properly.
- Forums
- ASX - By Stock
- General discussion
Otsuka Pharma (Japanese) just bid CAD$80m (Aussie $90m) for...
-
- There are more pages in this discussion • 3,010 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online